Show simple item record

dc.contributor.authorSivis, Zuhal O.
dc.contributor.authorTÜFEKÇİ, ÖZLEM
dc.contributor.authorBAHADIR, AYŞENUR
dc.contributor.authorVural, Sema
dc.contributor.authorBayhan, Turan
dc.contributor.authorYarali, Husniye N.
dc.contributor.authorCelkan, Tiraje
dc.contributor.authorOzbek, Namik Y.
dc.contributor.authorKaraman, Serap
dc.contributor.authorBilir, Ozlem A.
dc.contributor.authorDikme, Gurcan
dc.contributor.authorMalbora, Baris
dc.contributor.authorSEZGİN EVİM, MELİKE
dc.date.accessioned2021-12-10T11:19:05Z
dc.date.available2021-12-10T11:19:05Z
dc.date.issued2021
dc.identifier.citationBilir O. A. , Dikme G., Malbora B., SEZGİN EVİM M., Sivis Z. O. , TÜFEKÇİ Ö., BAHADIR A., Karaman S., Vural S., Bayhan T., et al., "Posterior Reversible Encephalopathy Syndrome in Childhood Hematological/Oncological Diseases: Multicenter Results", JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, cilt.43, sa.4, 2021
dc.identifier.issn1077-4114
dc.identifier.otherav_765ccf28-cc50-43f0-a882-15b566bd120a
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/171655
dc.identifier.urihttps://doi.org/10.1097/mph.0000000000001965
dc.description.abstractThe aim of the study was to analyze the characteristics of posterior reversible encephalopathy syndrome (PRES) cases treated at 10 different institutions in our country. Fifty-eight patients diagnosed with PRES were included in this study. The data of PRES cases from 10 departments of pediatric hematology/oncology were analyzed. The mean age of the patients at the time of diagnosis of PRES was 8.95 +/- 3.66 years. Most patients (80.4%) had a primary diagnosis of acute leukemia. Patients received chemotherapy (71.4%) and/or used steroids within 14 days before the diagnosis of PRES (85.7%). Hypertension was found in 83.9% of the patients. Twenty-six patients had infections and 22 of them had febrile neutropenia. The most common electrolyte disorders were hypocalcemia, hypomagnesemia, and hypopotassemia. Six patients had tumor lysis syndrome and 4 had inappropriate antidiuretic hormone syndrome. Magnetic resonance imaging was used for diagnosis in all patients. The most commonly involved regions by magnetic resonance imaging were occipital (58%), parietal (51%), and frontal lobes (45%), respectively. Twenty-five patients required intensive care and 7 patients were intubated. In conclusion, PRES may develop during the follow-up and treatment of hematological diseases. In addition to steroid and intense combined chemotherapies, immunosuppressive agents and hypertension are also factors that may be responsible for PRES.
dc.language.isoeng
dc.subjectOncology
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectHEMATOLOJİ
dc.subjectPEDİATRİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectOnkoloji
dc.subjectPediatrics
dc.subjectPediatrics, Perinatology and Child Health
dc.subjectHematology
dc.subjectHealth Sciences
dc.titlePosterior Reversible Encephalopathy Syndrome in Childhood Hematological/Oncological Diseases: Multicenter Results
dc.typeMakale
dc.relation.journalJOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
dc.contributor.departmentCity Hospital Ankara , ,
dc.identifier.volume43
dc.identifier.issue4
dc.contributor.firstauthorID2636200


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record